Literature DB >> 7582558

Calcitonin gene-related peptide (CGRP)-enhanced non-adrenergic non-cholinergic contraction of guinea-pig proximal colon.

S Kojima1, Y Shimo.   

Abstract

1. We have investigated the effect of calcitonin gene-related peptide (CGRP) on non-adrenergic, non-cholinergic (NANC) excitatory transmission to the longitudinal muscle of the guinea-pig proximal colon. 2. In the presence of atropine (0.3 microM), guanethidine (5 microM), hexamethonium (100 microM) and indomethacin (3 microM), electrical field stimulation (EFS, 1 Hz, 0.3 ms for 10 s) produced tetrodotoxin-(300 nM)-sensitive contractions which were reduced by the combined administration of FK 888 (10 microM) and MEN 10,376 (0.3 microM), to block tachykinin NK1 and NK2 receptors, respectively. Thus, the EFS-induced NANC contractions are a tachykinin-mediated response. 3. CGRP, at concentrations higher than 0.1 nM, caused an increase in the electrically-evoked, NANC contractions in a concentration-dependent manner and at 10 nM produced a maximal effect (pEC50 = 9.20 +/- 0.17, n = 6). 4. 5-Hydroxytryptamine (5-HT, 1-100 nM) also caused an increase in the EFS-induced NANC contractions in a concentration-dependent manner and at 30 nM produced a maximal effect (pEC50 = 8.06 +/- 0.09, n = 4), but calcitonin (10-100 nM) failed to enhance the EFS-induced NANC responses. Moreover, a 5-HT4 receptor antagonist, DAU 6285 (3 microM) abolished the enhancing action of 5-HT (30 nM). 5. The combined administration of FK 888 (10 microM) plus MEN 10,376 (0.3 microM) abolished the enhancement of EFS-induced NANC contractions by CGRP (10 nM), but DAU 6285 (3 microM) had no effect on the enhancement. 6. Human CGRP8-37 (1 microM), a CGRP1 receptor antagonist had no effect on the submaximal enhancement of the electrically-evoked, NANC contractions by CGRP (1 nM).7. CGRP (30 nM) had no effect on contractions evoked by exogenous substance P (0.3-1 nM).8. These results indicate that in the guinea-pig proximal colon, CGRP produced an enhancement ofNANC contraction induced by EFS through prejunctional mechanisms and that the enhancement is mediated by the stimulation of non-CGRP1 receptors located on intramural tachykininergic neurones.Further, the possible contribution of 5-HT to the enhancing effect of CGRP appeared to be negligible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582558      PMCID: PMC1908780          DOI: 10.1111/j.1476-5381.1995.tb15038.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Characterization of 5-hydroxytryptamine-induced relaxations of guinea-pig proximal colon.

Authors:  S Kojima
Journal:  Arch Int Pharmacodyn Ther       Date:  1991 Sep-Oct

2.  Calcitonin gene-related peptide action on intestinal circular muscle.

Authors:  P Holzer; L Barthó; O Matusák; V Bauer
Journal:  Am J Physiol       Date:  1989-03

Review 3.  Calcitonin gene-related peptide in the nervous tissue.

Authors:  A Ishida-Yamamoto; M Tohyama
Journal:  Prog Neurobiol       Date:  1989       Impact factor: 11.685

4.  Calcitonin gene-related peptide excites myenteric neurons.

Authors:  J M Palmer; M Schemann; K Tamura; J D Wood
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

5.  Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues.

Authors:  D Goltzman; J Mitchell
Journal:  Science       Date:  1985-03-15       Impact factor: 47.728

6.  hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.

Authors:  T Dennis; A Fournier; A Cadieux; F Pomerleau; F B Jolicoeur; S St Pierre; R Quirion
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

7.  Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A.

Authors:  P Holzer; P H Guth
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

8.  Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.

Authors:  A Dumuis; H Gozlan; M Sebben; H Ansanay; C A Rizzi; M Turconi; E Monferini; E Giraldo; P Schiantarelli; H Ladinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

9.  Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus.

Authors:  J Rodrigo; J M Polak; L Fernandez; M A Ghatei; P Mulderry; S R Bloom
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

10.  Extrinsic origin of the capsaicin-sensitive innervation of rat duodenum: possible involvement of calcitonin gene-related peptide (CGRP) in the capsaicin-induced activation of intramural non-adrenergic non-cholinergic neurons.

Authors:  C A Maggi; S Manzini; S Giuliani; P Santicioli; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

View more
  4 in total

1.  Calcitonin gene-related peptide facilitates serotonin release from guinea-pig colonic mucosa via myenteric neurons and tachykinin NK2/NK3 receptors.

Authors:  Shu-Ichi Kojima; Shuichi Ueda; Masashi Ikeda; Yuichiro Kamikawa
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

Review 2.  Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide's Motor-Stimulating and Prosecretory Function in the Intestine.

Authors:  Peter Holzer; Ulrike Holzer-Petsche
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

Review 3.  An Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic Mucosa.

Authors:  Shu-ichi Kojima; Atsushi Tohei; Masashi Ikeda; Naohiko Anzai
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

4.  Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231LUC+).

Authors:  Silvia Gutierrez; M Danilo Boada
Journal:  Cancer Cell Int       Date:  2018-12-22       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.